University of Florida has backed a second round for Atsena, a vision loss therapy developer exploiting inventions the institution had originally licensed to Sanofi.

Amazon Climate Pledge Fund and Shell Ventures both participated in a $21.4m round that will support development of ZeroAvia's hydrogen aircraft powertrain.

The exosite drug developer has launched publicly to advance research from Harvard University and Salk Institute for Biological Studies.

Novartis Venture Fund is among the participants in a series A round disclosed by the exosite drug developer at its public launch.

Shure contributed to a series A round that will support the livestreaming platform developer's innovation, sales and marketing activities.

The neurodegenerative disorder drug developer has emerged from stealth to commercialise Howard Hughes Medical Institute research.

Cemex-backed last-mile delivery service GoFor has closed a $15.7m round that will support its growth in the United States.

Samsung’s Catalyst helped the industrial exoskeleton provider close a series A round that will go to advancing the company's international expansion.

Hochland, Tnuva and Tempo all contributed to an $11.3m round that will help the vegan dairy protein developer bolster its production and distribution.

Eli Lilly, Novartis Venture Fund and AbbVie Ventures are among the contributors to a series A round disclosed as the neurodegenerative disorder drug developer emerged from stealth.